33490645|t|Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells.
33490645|a|Ellagitannins (esters composed of glucose and ellagic acid) are hydrolyzed to generate ellagic acid in gut followed by conversion of ellagic acid to urolithins such as urolithin A by intestinal bacteria. Since urolithins are absorbed by gut easier than ellagitannins and ellagic acid, and show various physiological activities (e.g. anti-cancer, anti-cardiovascular disease, anti-diabetes mellitus, anti-obesity and anti-Alzheimer disease activities), they are expected as excellent health-promoting phytochemicals. Here, using human monoblast U937 cells, we investigated the effect of ellagic acid and urolithin A on the superoxide anion (O2 -)-generating system of phagocytes, which is consisted of five specific protein factors (membrane proteins: p22-phox and gp91-phox, cytosolic proteins: p40-phox, p47-phox and p67-phox). Twenty micromolar of urolithin A enhanced the all-trans retinoic acid (ATRA)-induced O2 --generating activity (to ~175%) while 20 muM ellagic acid inhibited the ATRA-induced O2 --generating activity (to ~70%). Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to ~70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to ~160%) in ATRA plus urolithin A-treated cells. Chromatin immunoprecipitation assay suggested that urolithin A enhanced acetylations of Lys-9 residues of histone H3 within chromatin surrounding the promoter region of gp91-phox gene, but ellagic acid suppressed the acetylations. Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%). These results suggested that conversion of ellagic acid to urolithin A in gut may bring about reverse effects on the gp91-phox gene expression, resulting in opposite alterations in O2 --generating activity of intestinal macrophages.
33490645	0	12	Ellagic acid	Chemical	MESH:D004610
33490645	45	56	urolithin A	Chemical	MESH:C026423
33490645	85	94	gp91-phox	Gene	1536
33490645	149	172	all-trans retinoic acid	Chemical	MESH:D014212
33490645	181	191	superoxide	Chemical	MESH:D013481
33490645	215	219	U937	CellLine	CVCL:0007
33490645	227	240	Ellagitannins	Chemical	MESH:D047348
33490645	242	248	esters	Chemical	MESH:D004952
33490645	261	268	glucose	Chemical	MESH:D005947
33490645	273	285	ellagic acid	Chemical	MESH:D004610
33490645	314	326	ellagic acid	Chemical	MESH:D004610
33490645	360	372	ellagic acid	Chemical	MESH:D004610
33490645	376	386	urolithins	Chemical	-
33490645	437	447	urolithins	Chemical	-
33490645	480	493	ellagitannins	Chemical	MESH:D047348
33490645	498	510	ellagic acid	Chemical	MESH:D004610
33490645	565	571	cancer	Disease	MESH:D009369
33490645	578	600	cardiovascular disease	Disease	MESH:D002318
33490645	607	624	diabetes mellitus	Disease	MESH:D003920
33490645	631	638	obesity	Disease	MESH:D009765
33490645	648	665	Alzheimer disease	Disease	MESH:D000544
33490645	755	760	human	Species	9606
33490645	771	775	U937	CellLine	CVCL:0007
33490645	813	825	ellagic acid	Chemical	MESH:D004610
33490645	830	841	urolithin A	Chemical	MESH:C026423
33490645	849	865	superoxide anion	Chemical	MESH:D013481
33490645	867	871	O2 -	Chemical	MESH:D013481
33490645	978	986	p22-phox	Gene	1535
33490645	991	1000	gp91-phox	Gene	1536
33490645	1022	1030	p40-phox	Gene	4689
33490645	1032	1040	p47-phox	Gene	653361
33490645	1045	1053	p67-phox	Gene	4688
33490645	1077	1088	urolithin A	Chemical	MESH:C026423
33490645	1102	1125	all-trans retinoic acid	Chemical	MESH:D014212
33490645	1127	1131	ATRA	Chemical	MESH:D014212
33490645	1141	1145	O2 -	Chemical	MESH:D013481
33490645	1190	1202	ellagic acid	Chemical	MESH:D004610
33490645	1217	1221	ATRA	Chemical	MESH:D014212
33490645	1230	1234	O2 -	Chemical	MESH:D013481
33490645	1325	1334	gp91-phox	Gene	1536
33490645	1372	1376	ATRA	Chemical	MESH:D014212
33490645	1382	1394	ellagic acid	Chemical	MESH:D004610
33490645	1424	1433	gp91-phox	Gene	1536
33490645	1476	1480	ATRA	Chemical	MESH:D014212
33490645	1486	1497	urolithin A	Chemical	MESH:C026423
33490645	1682	1691	gp91-phox	Gene	1536
33490645	1702	1714	ellagic acid	Chemical	MESH:D004610
33490645	1778	1782	ATRA	Chemical	MESH:D014212
33490645	1788	1799	urolithin A	Chemical	MESH:C026423
33490645	1841	1849	p22-phox	Gene	1535
33490645	1865	1874	gp91-phox	Gene	1536
33490645	1895	1899	ATRA	Chemical	MESH:D014212
33490645	1905	1917	ellagic acid	Chemical	MESH:D004610
33490645	1961	1969	p22-phox	Gene	1535
33490645	1984	1993	gp91-phox	Gene	1536
33490645	2048	2060	ellagic acid	Chemical	MESH:D004610
33490645	2064	2075	urolithin A	Chemical	MESH:C026423
33490645	2122	2131	gp91-phox	Gene	1536
33490645	2186	2191	O2 --	Chemical	MESH:D013481
33490645	Positive_Correlation	MESH:D013481	MESH:D014212
33490645	Negative_Correlation	MESH:C026423	1536
33490645	Association	MESH:D013481	653361
33490645	Positive_Correlation	MESH:C026423	MESH:D013481
33490645	Negative_Correlation	MESH:D047348	MESH:D000544
33490645	Negative_Correlation	MESH:D004610	1536
33490645	Association	MESH:D013481	4689
33490645	Association	MESH:D013481	1536
33490645	Negative_Correlation	MESH:D004610	MESH:D009765
33490645	Negative_Correlation	MESH:D004610	MESH:D014212
33490645	Negative_Correlation	MESH:D047348	MESH:D009765
33490645	Association	MESH:D013481	1535
33490645	Association	MESH:D013481	4688
33490645	Association	MESH:D014212	1536
33490645	Negative_Correlation	MESH:C026423	MESH:D000544
33490645	Negative_Correlation	MESH:D004610	MESH:D013481
33490645	Positive_Correlation	MESH:C026423	1535
33490645	Positive_Correlation	MESH:D014212	1535
33490645	Negative_Correlation	MESH:C026423	MESH:D009765
33490645	Negative_Correlation	MESH:D004610	MESH:D000544
33490645	Positive_Correlation	MESH:C026423	MESH:D014212

